Motta, I., Cusinato, M., Ludman, A. J., Lachenal, N., Dodd, M., Soe, M., . . . Berry, C. (2024). How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial. Antimicrobial agents and chemotherapy, 68(7), e0053624. https://doi.org/10.1128/aac.00536-24
Citácia podle Chicago (17th ed.)Motta, Ilaria, et al. "How Much Should We Still Worry About QTc Prolongation in Rifampicin-resistant Tuberculosis? ECG Findings from TB-PRACTECAL Clinical Trial." Antimicrobial Agents and Chemotherapy 68, no. 7 (2024): e0053624. https://doi.org/10.1128/aac.00536-24.
Citácia podľa MLA (8th ed.)Motta, Ilaria, et al. "How Much Should We Still Worry About QTc Prolongation in Rifampicin-resistant Tuberculosis? ECG Findings from TB-PRACTECAL Clinical Trial." Antimicrobial Agents and Chemotherapy, vol. 68, no. 7, 2024, p. e0053624, https://doi.org/10.1128/aac.00536-24.